Monopar Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 74.7%
Portfolio Pulse from Benzinga Newsdesk
Monopar Therapeutics shares were halted due to a circuit breaker after a significant price increase, with the stock rising by 74.7%.
October 24, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Monopar Therapeutics experienced a significant stock price increase of 74.7%, leading to a trading halt due to a circuit breaker.
The stock price of Monopar Therapeutics increased significantly, triggering a circuit breaker halt. This indicates strong investor interest and potential positive sentiment, likely leading to further price movements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100